FDA Approves New Oral Antibiotic Blujepa For UTI Treatment In Women And Teens
The FDA has approved Blujepa (gepotidacin), a first-in-class oral antibiotic for uncomplicated urinary tract infections (uUTIs) in women and children aged 12 and older. Clinical trials showed its ...
Medical Dialogues4 天
GSK Blujepa bags USFDA nod for treatment of uUTIs in female adults, paediatric patients 12 ...
London: GSK plc has announced that the Company has received US Food and Drug Administration (FDA) approval for Blujepa ...
Contract Pharma4 天
GSK’s Blujepa Approved by FDA for Treatment of uUTIs
The FDA has approved GSK’s Blujepa for the treatment of female adults and pediatric patients with uncomplicated urinary tract ...
Fierce Pharma5 天
GSK ushers in new UTI antibiotic with FDA nod for first-in-class Blujepa
GSK is opening the door to a new era in urinary tract infection (UTI) treatment with its Blujepa, the first in a new class of ...
KTEN5 天
FDA Approves Blujepa for Uncomplicated Urinary Tract Infections
The U.S. Food and Drug Administration has approved Blujepa (gepotidacin) for the treatment of uncomplicated urinary tract ...
GSK confirms Blujepa approved by FDA for uUTIs
GSK (GSK) plc announced that the U.S. Food and Drug Administration has approved Blujepa for the treatment of female adults and pediatric ...
Nasdaq5 天
FDA Approves GSK' Blujepa For Treating Uncomplicated Urinary Tract Infections In Women ...
(GSK, GSK.L) announced that the US Food and Drug Administration has approved Blujepa (gepotidacin) for the treatment of female ... Klebsiella pneumoniae, Citrobacter freundii complex ...